Clinical access to Bedaquiline Programme for the treatment of drug-resistant tuberculosis

South African Medical Journal

Volumn 104, Issue 3, 2014, Pages 164-166

  Conradie, Francesca ^a   Meintjes, Graeme ^b   Hughes, Jennifer ^c   Maartens, Gary ^b   Ferreira, Hannetjie ^d   Siwendu, Sweetness ^e   Master, Iqbal ^f   Ndjeka, Norbert ^g  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Division of Clinical Pharmacology Department of Medicine University of Cape Town ^*

^d MDR XDR TB Unit   (South Africa)

^e Metro TB Hospital Complex at Brooklyn Chest Hospital   (South Africa)

^f King Dinuzulu Hospital   (South Africa)

^g TB and HIV National TB Control and Management National Department of Health   (South Africa)

Author keywords

Bedaquilline; Compassionate access; Drug resistant tuberculosis

Indexed keywords

BEDAQUILINE;

ARTICLE; DRUG RESISTANT TUBERCULOSIS; DRUG SAFETY; DRUG TREATMENT FAILURE; ELECTROCARDIOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DIARYLQUINOLINES; HEALTH SERVICES ACCESSIBILITY; HUMANS; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84894724176     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.7263     Document Type: Article

References (5)

1. Horsburgh CR, Haxaire-Theeuwes M, Wingfield C, et al. Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis. Int J Tuberc Lung Dis 2013;17(2):146-152. [http://dx.doi.org/10.5588/ijtld.12.0017]
2. World Health Organization. Global Tuberculosis Report 2013. Geneva: WHO, 2013. http://www.who.int/tb/publications/global_report/en/ (accessed 10 July 2013).
3. Dheda K, Shean K, Zumla A, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: A retrospective cohort study. Lancet 2010;375(9728):1798-1807. [http://dx.doi.org/10.1016/S0140-6736(10)60492-8]
4. Diacon AH, Pym AS, Grobusch M, et al. The diarylquinolone TMC 207 for the treatment ofmultidrug-resistant tuberculosis. N Engl J Med 2009;369(23):2397-2405. [http://dx.doi.org/10.1056/NEJMoa0808427]
5. Van Deun A, Maug AK, Salim MA, et al. Short, highly effective, and inexpensive standardizedtreatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2010;182(5):684-692.[http://dx.doi.org/10.1164/rccm.201001-0077OC]